aldosterone has been researched along with canrenone in 45 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 19 (42.22) | 18.7374 |
1990's | 6 (13.33) | 18.2507 |
2000's | 9 (20.00) | 29.6817 |
2010's | 8 (17.78) | 24.3611 |
2020's | 3 (6.67) | 2.80 |
Authors | Studies |
---|---|
Haga, N; Ishibashi, M; Itoh, T; Kamata, S; Matsui, T; Nakamura, M; Odaguchi, K; Shimizu, T; Suzuki, T; Yamada, F | 1 |
Chinn, LJ; Desai, BN; Salamon, KW | 1 |
Aumelas, A; Auzou, G; Claire, M; Faraj, H; Grassy, G; Rondot, A | 1 |
Claire, M; Corvol, P; Menard, J; Michaud, A; Rafestin-Oblin, ME; Roth-Meyer, C | 1 |
Hofmann, LM; Pedrera, HA; Suleymamov, OD | 1 |
Al-Dujaili, EA; Huston, GJ | 1 |
Erkkola, R; Lammintausta, R | 1 |
Aupetit, B; Duchier, J; Legrand, JC | 1 |
Erbler, HC | 1 |
Appenheimer, M; Glänzer, K; Herschbach, ML; Krück, F; Lucas, R; Vetter, H; Weiand, H; Witassek, F | 1 |
Erbler, HC; Hilfenhaus, M; Wernze, H | 1 |
Cheng, SC; Harding, BW; Sadee, W; Suzuki, K | 1 |
Erbler, HC; Hilfenhaus, M | 1 |
Hofmann, LM; Maibach, HI; Polk, RC | 1 |
Christ, M; Theisen, K; Wehling, M | 1 |
Käsmayr, J; Theisen, K; Wehling, M | 2 |
Lewicka, S; Vecsei, P; Weindel, K | 1 |
Boucher, RC; Gatzy, JT; Knowles, MR | 1 |
Buse, M; Casals-Stenzel, J; Losert, W | 1 |
Aperia, A; Larsson, L; Zetterström, R | 1 |
Claire, M; Corvol, P; Geering, K; Oblin, ME; Rossier, B | 1 |
Hettiarachchi, J; Ramsay, LE | 1 |
Colby, HD; Los, LE | 1 |
Aktas, J; Christ, M; Eisen, C; Theisen, K; Wehling, M | 1 |
Frömter, E; Rabe, A | 1 |
Sanderson, JE | 1 |
Casaburi, C; Cittadini, A; Di Gianni, A; Monti, MG; Saccà, L; Saldamarco, L; Scherillo, G; Serpico, R; Vanasia, M | 1 |
Caligiuri, A; De Franco, RM; Failli, P; Geerts, A; Gentilini, A; Gentilini, P; Marra, F; Mazzetti, L; Meucci, M; Pinzani, M; Romanelli, RG; Rombouts, K; Vanasia, M | 1 |
Fumeaux, Z; Mach, F; Martin, PY; Perneger, T; Rossier, M; Saudan, P; Schnetzler, B; Stoermann, C | 1 |
Armanini, D; Calò, LA; Davis, PA; De Mozzi, P; Fiore, C; Martire, G; Pagnin, E; Sartorato, P; Zaghetto, F | 1 |
Brunette, MG; Couchourel, D; Leclerc, M | 1 |
Boccanelli, A; Cacciatore, G; Clemenza, F; De Maria, R; de Simone, G; Di Lenarda, A; Gavazzi, A; Gonzini, L; Latini, R; Maggioni, AP; Masson, S; Mureddu, GF; Porcu, M; Vanasia, M | 1 |
Armanini, D; Calò, LA; Fiore, C; Pagnin, E; Ragazzi, E; Sartorato, P | 1 |
Bowalgaha, K; Knights, KM; Miners, JO | 1 |
Agostoni, P; Boccanelli, A | 1 |
Bianchi, L; Bonaventura, A; D'Angelo, A; Derosa, G; Fogari, E; Maffioli, P; Romano, D | 1 |
Armanini, D; Bordin, L; Clari, G; Donà, G; Sabbadin, C | 1 |
D'Elia, E; Krum, H | 1 |
Bianchi, L; D'Angelo, A; Derosa, G; Maffioli, P; Romano, D | 1 |
Channar, PA; El-Seedi, H; Faisal, M; Larik, FA; Mehfooz, H; Saeed, A; Shahzad, D | 1 |
Caroccia, B; Domening, O; Iacobone, M; Lenzini, L; Pallafacchina, G; Piazza, M; Poglitsch, M; Prisco, S; Rizzuto, R; Rossi, GP; Seccia, TM; Zanin, S | 1 |
Ceolotto, G; Cesari, M; Maiolino, G; Rossi, GP; Rossitto, G; Seccia, TM | 1 |
Armanini, D; Boscaro, M; Sabbadin, C | 1 |
Avataneo, V; Bertello, C; Buffolo, F; Burrello, J; D'Avolio, A; Mengozzi, G; Monticone, S; Mulatero, P; Pecori, A; Rabbia, F; Rumbolo, F; Veglio, F | 1 |
3 review(s) available for aldosterone and canrenone
Article | Year |
---|---|
Spirolactones: clinical and pharmacologic studies.
Topics: Aldosterone; Animals; Binding, Competitive; Canrenoic Acid; Canrenone; Diuresis; Humans; Hyperaldosteronism; Hypertension; In Vitro Techniques; Kidney; Mineralocorticoid Receptor Antagonists; Pregnadienes; Protein Binding; Rats; Receptors, Cell Surface; Spironolactone | 1977 |
Mechanism of the antimineralocorticoid effects of spirolactones.
Topics: Aldosterone; Animals; Anura; Canrenoic Acid; Canrenone; Cattle; Guinea Pigs; Humans; Male; Mineralocorticoid Receptor Antagonists; Rats; Receptors, Steroid; Spironolactone; Veratrum Alkaloids | 1981 |
Synthetic approaches towards the multi target drug spironolactone and its potent analogues/derivatives.
Topics: Aldosterone; Androstadienes; Androstenes; Animals; Canrenone; Chloranil; Dehydroepiandrosterone; Eplerenone; Humans; Molecular Structure; Receptors, Mineralocorticoid; Spironolactone | 2017 |
5 trial(s) available for aldosterone and canrenone
Article | Year |
---|---|
Spironolactone in thiazide-induced hypokalaemia: variable response between patients.
Topics: Adult; Aldosterone; Benzothiadiazines; Canrenone; Diuretics; Electrolytes; Female; Humans; Hypokalemia; Male; Middle Aged; Potassium; Sodium Chloride Symporter Inhibitors; Spironolactone | 1981 |
Safety of low-dose spironolactone administration in chronic haemodialysis patients.
Topics: Adult; Aged; Aldosterone; Canrenone; Humans; Hyperkalemia; Kidney Failure, Chronic; Middle Aged; Mineralocorticoid Receptor Antagonists; Potassium; Renal Dialysis; Spironolactone | 2003 |
Baseline characteristics of patients recruited in the AREA IN-CHF study (Antiremodelling Effect of Aldosterone Receptors Blockade with Canrenone in Mild Chronic Heart Failure).
Topics: Aged; Aldosterone; Biomarkers; Canrenone; Disease Progression; Double-Blind Method; Echocardiography; Female; Heart Failure; Humans; Male; Middle Aged; Mineralocorticoid Receptor Antagonists; Ventricular Dysfunction, Left; Ventricular Remodeling | 2007 |
Effects of canrenone in patients with metabolic syndrome.
Topics: Aged; Aldosterone; Blood Glucose; Blood Pressure; C-Reactive Protein; Canrenone; Female; Humans; Insulin Resistance; Male; Metabolic Syndrome; Middle Aged; Mineralocorticoid Receptor Antagonists; Natriuretic Peptide, Brain; Tumor Necrosis Factor-alpha | 2013 |
The effects of canrenone on inflammatory markers in patients with metabolic syndrome.
Topics: Aged; Aldosterone; Biomarkers; Blood Glucose; Blood Pressure; Body Mass Index; Body Weight; Canrenone; Creatine; Double-Blind Method; Fasting; Female; Humans; Inflammation; Lipids; Lipoproteins; Male; Metabolic Syndrome; Metalloproteases; Middle Aged; Natriuretic Peptide, Brain; Peroxidase; Potassium; White People | 2015 |
37 other study(ies) available for aldosterone and canrenone
Article | Year |
---|---|
Aldosterone antagonists. 2. Synthesis and biological activities of 11,12-dehydropregnane derivatives.
Topics: Adrenalectomy; Animals; Kidney; Male; Mineralocorticoid Receptor Antagonists; Rats; Rats, Inbred Strains; Receptors, Androgen; Receptors, Mineralocorticoid; Receptors, Progesterone; Receptors, Steroid; Structure-Activity Relationship | 1987 |
A structure-activity relationship study of spirolactones. Contribution of the cyclopropane ring to antimineralocorticoid activity.
Topics: Chemical Phenomena; Chemistry; Mineralocorticoid Receptor Antagonists; Mineralocorticoids; Molecular Conformation; Receptors, Mineralocorticoid; Receptors, Steroid; Spironolactone; Structure-Activity Relationship | 1981 |
Synthesis of new 11 beta-substituted spirolactone derivatives. Relationship with affinity for mineralocorticoid and glucocorticoid receptors.
Topics: Adrenalectomy; Aldosterone; Animals; Dexamethasone; Kidney; Rabbits; Receptors, Glucocorticoid; Spironolactone; Structure-Activity Relationship | 1993 |
Aldosterone antagonism studies in the rhesus monkey.
Topics: Administration, Oral; Aldosterone; Animals; Canrenone; Diuresis; Dose-Response Relationship, Drug; Female; Haplorhini; Hydrochlorothiazide; Injections, Intramuscular; Macaca mulatta; Mineralocorticoid Receptor Antagonists; Potassium; Sodium; Spironolactone | 1977 |
A comparison of some extra-renal effects of spironolactone and canrenone.
Topics: Aldosterone; Canrenone; Humans; Male; Membrane Potentials; Middle Aged; Mineralocorticoid Receptor Antagonists; Pregnadienes; Pressure; Rectum; Spironolactone; Time Factors | 1979 |
Effect of spironolactone treatment on the renin-aldosterone system during pregnancy.
Topics: Aldosterone; Canrenone; Female; Humans; Potassium; Pregnancy; Renin; Sodium; Spironolactone; Time Factors | 1979 |
[Effect of spironolactones on aldosterone synthesis and adrenal metabolism].
Topics: Adrenal Glands; Aldosterone; Animals; Canrenoic Acid; Canrenone; Ducks; Hydroxylation; Mineralocorticoid Receptor Antagonists; Mitochondria; Mitochondria, Liver; Oxidative Phosphorylation; Sheep; Spironolactone; Steroid Hydroxylases | 1978 |
Effect of spironolactone and its main metabolite canrenone on the renin-angiotensin-aldosterone-system during long-term treatment in rats.
Topics: Administration, Oral; Aldosterone; Angiotensin II; Animals; Canrenone; Dose-Response Relationship, Drug; Male; Pregnadienes; Rats; Renin; Spironolactone; Time Factors; Water-Electrolyte Balance | 1979 |
Effect of a spirolactone on plasma and urinary aldosterone in primary aldosteronism.
Topics: Adenoma; Adrenal Gland Neoplasms; Aldosterone; Canrenone; Female; Glucuronates; Humans; Hyperaldosteronism; Kinetics; Potassium; Pregnadienes; Renin | 1977 |
Effect of aldosterone antagonist canrenone on plasma aldosterone concentration and plasma renin activity, and on the excretion of aldosterone and electrolytes by man.
Topics: Aldosterone; Canrenone; Diabetes Mellitus; Diuresis; Dose-Response Relationship, Drug; Female; Humans; Methods; Middle Aged; Potassium; Pregnadienes; Renin; Sodium | 1976 |
Effects of spironolactone, canrenone and canrenoate-K on cytochrome P450, and 11beta- and 18-hydroxylation in bovine and human adrenal cortical mitochondria.
Topics: Adenoma; Adrenal Cortex; Adrenal Gland Neoplasms; Adrenal Glands; Aldosterone; Animals; Canrenoic Acid; Canrenone; Cattle; Cytochrome P-450 Enzyme System; Humans; Hyperplasia; Mitochondria; Oxidation-Reduction; Pregnadienes; Spectrum Analysis; Spironolactone; Steroid Hydroxylases | 1976 |
Proceedings: Acute and chronic effects of the aldosterone antagonist spironolactone and its main metabolite canrenone on plasma aldosterone concentration, plasma renin activity, serum electrolytes and on the excretion of aldosterone, fluid and electrolyte
Topics: Aldosterone; Animals; Canrenone; Electrolytes; Male; Pregnadienes; Rats; Renin; Spironolactone | 1975 |
Renal clearance of canrenoate in normal man.
Topics: 17-Ketosteroids; Aldosterone; Canrenoic Acid; Canrenone; Humans; Hydroxysteroids; Kidney; Kidney Function Tests; Male; Metabolic Clearance Rate; Pregnadienes; Renin | 1975 |
High affinity aldosterone binding to plasma membrane rich fractions from mononuclear leukocytes: is there a membrane receptor for mineralocorticoids?
Topics: Aldosterone; Binding, Competitive; Canrenone; Cell Membrane; Cloning, Molecular; Humans; Hydrocortisone; Kinetics; Leukocytes, Mononuclear; Receptors, Glucocorticoid; Receptors, Mineralocorticoid; Receptors, Steroid; Recombinant Proteins | 1991 |
Rapid effects of mineralocorticoids on sodium-proton exchanger: genomic or nongenomic pathway?
Topics: Aldosterone; Calcium; Canrenoic Acid; Canrenone; Carrier Proteins; Dexamethasone; DNA; Humans; Hydrocortisone; In Vitro Techniques; Kinetics; Leukocytes, Mononuclear; Models, Biological; Potassium; Propionates; Reference Values; Sodium; Sodium-Hydrogen Exchangers | 1991 |
Aldosterone influences free intracellular calcium in human mononuclear leukocytes in vitro.
Topics: Adolescent; Adult; Aged; Aldosterone; Amiloride; Calcium; Canrenoic Acid; Canrenone; Corticosterone; Cycloheximide; Dactinomycin; Humans; Hydrocortisone; Leukocytes, Mononuclear; Middle Aged | 1990 |
Comparative dose-effect studies with four C-17-spirosteroidal mineralocorticoid synthesis inhibitors.
Topics: Aldosterone; Analysis of Variance; Animals; Canrenone; Male; Mineralocorticoid Receptor Antagonists; Mineralocorticoids; Oxazoles; Pregnadienes; Rats; Rats, Inbred Strains; Spiro Compounds; Spironolactone; Zona Glomerulosa | 1989 |
Aldosterone metabolism and transepithelial potential difference in normal and cystic fibrosis subjects.
Topics: Adult; Aldosterone; Canrenone; Cystic Fibrosis; Electrophysiology; Epithelium; Female; Humans; Male; Nose; Rectum; Reference Values; Spironolactone | 1985 |
Progestogens with antimineralocorticoid activity.
Topics: Adrenalectomy; Aldosterone; Androstadienes; Androstenes; Animals; Canrenoic Acid; Canrenone; Cyproterone; Dose-Response Relationship, Drug; Male; Mineralocorticoid Receptor Antagonists; Mineralocorticoids; Norethindrone; Norgestrel; Norpregnenes; Potassium; Progesterone; Progesterone Congeners; Rats; Rats, Inbred Strains; Sodium; Spironolactone | 1985 |
Hormonal induction of Na-K-ATPase in developing proximal tubular cells.
Topics: Aging; Aldosterone; Animals; Betamethasone; Canrenone; Dose-Response Relationship, Drug; Enzyme Induction; Estrogens; Kidney Tubules, Proximal; Male; Rats; Receptors, Glucocorticoid; Sodium-Potassium-Exchanging ATPase | 1981 |
Binding of spironolactone metabolites in vivo to renal mineralocorticoid receptors in guinea pigs.
Topics: Aldosterone; Animals; Binding, Competitive; Canrenone; Guinea Pigs; Kidney; Male; Receptors, Mineralocorticoid; Spironolactone | 1994 |
The inositol-1,4,5-trisphosphate system is involved in rapid effects of aldosterone in human mononuclear leukocytes.
Topics: Adult; Aldosterone; Calcium; Canrenone; Concanavalin A; Humans; Hydrocortisone; Inositol 1,4,5-Trisphosphate; Leukocytes, Mononuclear; Male; Sodium-Hydrogen Exchangers; Terpenes; Thapsigargin | 1993 |
Micromolar concentrations of steroids and of aldosterone antagonists inhibit the outwardly rectifying chloride channel with different kinetics.
Topics: Aldosterone; Anti-Inflammatory Agents; Canrenone; Chloride Channels; Corticosterone; Cytosol; Dose-Response Relationship, Drug; Estradiol; HT29 Cells; Humans; Hydrocortisone; Ion Channel Gating; Kinetics; Lipids; Mineralocorticoid Receptor Antagonists; Patch-Clamp Techniques; Progesterone; Spironolactone; Testosterone | 2000 |
New treatments for myocardial fibrosis.
Topics: Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Animals; Canrenone; Clinical Trials as Topic; Endomyocardial Fibrosis; Heart Failure; Humans; Mineralocorticoid Receptor Antagonists; Myocardial Infarction; Rats; Spironolactone | 2002 |
Effects of canrenone on myocardial reactive fibrosis in a rat model of postinfarction heart failure.
Topics: Administration, Oral; Aldosterone; Animals; Canrenone; Collagen; Cyclodextrins; Disease Models, Animal; Dose-Response Relationship, Drug; Endomyocardial Fibrosis; gamma-Cyclodextrins; Heart Failure; Hemodynamics; Hydroxyproline; Male; Mineralocorticoid Receptor Antagonists; Myocardial Infarction; Myocardium; Rats; Rats, Sprague-Dawley; Ventricular Function, Left | 2002 |
Antifibrogenic effects of canrenone, an antialdosteronic drug, on human hepatic stellate cells.
Topics: Aldosterone; Amiloride; Calcium; Canrenone; Cell Division; Cell Movement; Cells, Cultured; Extracellular Matrix Proteins; Focal Adhesion Kinase 1; Focal Adhesion Protein-Tyrosine Kinases; Guanidines; Humans; Hydrogen-Ion Concentration; Intracellular Membranes; Liver; Liver Cirrhosis; Mineralocorticoid Receptor Antagonists; Phosphatidylinositol 3-Kinases; Phosphorylation; Platelet-Derived Growth Factor; Protein-Tyrosine Kinases; Signal Transduction; Sodium-Hydrogen Exchangers; Sulfones; Thrombin | 2003 |
Effect of aldosterone and glycyrrhetinic acid on the protein expression of PAI-1 and p22(phox) in human mononuclear leukocytes.
Topics: Adult; Aldosterone; Canrenone; Dose-Response Relationship, Drug; Drug Synergism; Female; Glycyrrhetinic Acid; Humans; Leukocytes, Mononuclear; Male; Membrane Transport Proteins; Mineralocorticoid Receptor Antagonists; NADPH Dehydrogenase; NADPH Oxidases; Phosphoproteins; Plasminogen Activator Inhibitor 1 | 2004 |
Aldosterone enhances renal calcium reabsorption by two types of channels.
Topics: Absorption; Aldosterone; Animals; Biological Transport; Calcium; Calcium Channels, L-Type; Calcium Channels, T-Type; Canrenone; Cycloheximide; Kidney; Kidney Tubules, Distal; Kidney Tubules, Proximal; Kinetics; Membranes; Mineralocorticoid Receptor Antagonists; Protein Synthesis Inhibitors; Rabbits; Second Messenger Systems; Sodium; Spironolactone; Time Factors | 2004 |
Effect of canrenone and amiloride on the prooxidative effect induced by aldosterone in human mononuclear leukocytes in vitro.
Topics: Adult; Aldosterone; Amiloride; Canrenone; Female; Humans; Hydrocortisone; Leukocytes, Mononuclear; Male; Mineralocorticoid Receptor Antagonists; NADPH Oxidases; Sodium Channel Blockers | 2009 |
Spironolactone and canrenone inhibit UGT2B7-catalyzed human liver and kidney microsomal aldosterone 18beta-glucuronidation: a potential drug interaction.
Topics: Aldosterone; Binding, Competitive; Canrenoic Acid; Canrenone; Drug Interactions; Glucuronosyltransferase; Humans; Hymecromone; In Vitro Techniques; Kidney; Microsomes; Microsomes, Liver; Spironolactone | 2010 |
[The EMPHASIS-HF study].
Topics: Aldosterone; Biomarkers; Canrenone; Cause of Death; Double-Blind Method; Early Termination of Clinical Trials; Eplerenone; Female; Heart Failure; Hospitalization; Humans; Hyperkalemia; Male; Mineralocorticoid Receptor Antagonists; Models, Cardiovascular; Molecular Structure; Multicenter Studies as Topic; Myocardial Infarction; Patient Selection; Randomized Controlled Trials as Topic; Renin-Angiotensin System; Research Design; Risk; Spironolactone | 2011 |
Aldosterone receptor blockers spironolactone and canrenone: two multivalent drugs.
Topics: Albuminuria; Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Canrenone; Humans; Hypertension; Inflammation; Insulin Resistance; Mineralocorticoid Receptor Antagonists; Spironolactone | 2014 |
Mineralcorticoid antagonists in heart failure.
Topics: Aldosterone; Canrenone; Clinical Trials as Topic; Heart Failure; Humans; Mineralocorticoid Receptor Antagonists | 2014 |
Aldosterone Stimulates Its Biosynthesis Via a Novel GPER-Mediated Mechanism.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Aldosterone; Benzodioxoles; Calcium; Canrenone; Cytochrome P-450 CYP11B2; Gene Expression Regulation, Neoplastic; Humans; Mineralocorticoid Receptor Antagonists; Quinolines; Receptor, Angiotensin, Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Renin-Angiotensin System; Tumor Cells, Cultured | 2019 |
Effects of Mineralocorticoid and AT1 Receptor Antagonism on The Aldosterone-Renin Ratio In Primary Aldosteronism-the EMIRA Study.
Topics: Aldosterone; Angiotensin II Type 1 Receptor Blockers; Canrenone; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hyperaldosteronism; Imidazoles; Male; Middle Aged; Mineralocorticoid Receptor Antagonists; Prognosis; Prospective Studies; Receptor, Angiotensin, Type 1; Renin; Renin-Angiotensin System; Tetrazoles | 2020 |
Primary aldosteronism: considerations about the evaluation of the aldosterone to renin ratio during canrenone treatment.
Topics: Aldosterone; Antihypertensive Agents; Canrenone; Diagnostic Techniques, Endocrine; Duration of Therapy; Humans; Hyperaldosteronism; Hypertension; Hypokalemia; Mineralocorticoid Receptor Antagonists; Renin; Renin-Angiotensin System; Reproducibility of Results | 2021 |
Mineralocorticoid Receptor Antagonist Effect on Aldosterone to Renin Ratio in Patients With Primary Aldosteronism.
Topics: Adolescent; Adrenalectomy; Adult; Aged; Aldosterone; Canrenone; Cohort Studies; False Negative Reactions; Female; Guidelines as Topic; Humans; Hyperaldosteronism; Hypertension; Male; Mass Screening; Medication Adherence; Middle Aged; Mineralocorticoid Receptor Antagonists; Potassium; Prospective Studies; Renin; Reproducibility of Results; Young Adult | 2021 |